JPRN-UMIN000014521已完成未知
Effects of SGLT2 inhibitor (Suglat) on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test. - The insulin resistance improvement effect of SGLT2 inhibitor (Suglat) in type 2 diabetes mellitus.
Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine0 个研究点目标入组 20 人开始时间: 2014年7月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes mellitus, pancreatic disease, liver disease, renal failure, or those taking diabetogenic medications such as corticosteroids
研究者
相似试验
已完成
不适用
Effects of SGLT2 inhibitor on insulin resistance possbly through the amelioration of glucose toxicitytype 2 diabetes mellitusJPRN-UMIN000029064Division of Endocrinology and Metabolism, Faculty of Internal Medicine, Kurume University Shcool of Medicine20
已完成
不适用
The Effect of SGLT2 inhibitors on blood glucose variability in patients with type 1 diabetestype 1 diabetes mellitusJPRN-UMIN000039361Hokkaido University Hospital30
已完成
不适用
Effect of sitagliptin on insulin secretion and glucose metabolism in Japanese patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000006401Osaka University Graduate School of Medicine20
招募中
不适用
Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitustype 2 Diabetes MellitusJPRN-UMIN000017461ephrology, endocrinology and vascular medicine at Tohoku University Hospital60
尚未招募
不适用
Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetesType 2 diabetes mellitusJPRN-UMIN000015402Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital30